These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 12828485)

  • 41. [Hallucinogenic mushrooms in Denmark].
    Holm JW; Ebbehøj NE; Fjeldberg IA
    Ugeskr Laeger; 1997 Aug; 159(34):5116-8. PubMed ID: 9297322
    [No Abstract]   [Full Text] [Related]  

  • 42. Analysis of psilocybin and psilocin in mushroom extracts by reversed-phase high performance liquid chromatography.
    Thomson BM
    J Forensic Sci; 1980 Oct; 25(4):779-85. PubMed ID: 7191888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Forensic analysis of hallucinogenic fungi: a DNA-based approach.
    Nugent KG; Saville BJ
    Forensic Sci Int; 2004 Mar; 140(2-3):147-57. PubMed ID: 15036436
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis of a psilocin hapten and a protein-hapten conjugate.
    Albers C; Lehr M; Beike J; Köhler H; Brinkmann B
    J Pharm Pharmacol; 2002 Sep; 54(9):1265-70. PubMed ID: 12356281
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
    Madsen MK; Fisher PM; Burmester D; Dyssegaard A; Stenbæk DS; Kristiansen S; Johansen SS; Lehel S; Linnet K; Svarer C; Erritzoe D; Ozenne B; Knudsen GM
    Neuropsychopharmacology; 2019 Jun; 44(7):1328-1334. PubMed ID: 30685771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Microscopic study of powders of hallucinogenic mushrooms--Psilocybe sp].
    Schäfer AT
    Arch Kriminol; 2000; 205(1-2):30-6. PubMed ID: 10726173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Automutilation after consumption of hallucinogenic mushrooms].
    Attema-de Jonge ME; Portier CB; Franssen EJ
    Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2869-72. PubMed ID: 18257429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Therapeutic Potential of Psilocybin.
    Lowe H; Toyang N; Steele B; Valentine H; Grant J; Ali A; Ngwa W; Gordon L
    Molecules; 2021 May; 26(10):. PubMed ID: 34063505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin.
    Sherwood AM; Halberstadt AL; Klein AK; McCorvy JD; Kaylo KW; Kargbo RB; Meisenheimer P
    J Nat Prod; 2020 Feb; 83(2):461-467. PubMed ID: 32077284
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes.
    Nkadimeng SM; Steinmann CML; Eloff JN
    Sci Rep; 2020 Dec; 10(1):22314. PubMed ID: 33339902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative analysis of psilocybin and psilocin in psilocybe baeocystis (Singer and Smith) by high-performance liquid chromatography and by thin-layer chromatography.
    Beug MW; Bigwood J
    J Chromatogr; 1981 Mar; 207(3):379-85. PubMed ID: 7194879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma psilocin critically determines behavioral and neurobiological effects of psilocybin.
    Madsen MK; Knudsen GM
    Neuropsychopharmacology; 2021 Jan; 46(1):257-258. PubMed ID: 32843702
    [No Abstract]   [Full Text] [Related]  

  • 53. Psilocin identified in a DUID investigation.
    Tiscione NB; Miller MI
    J Anal Toxicol; 2006 Jun; 30(5):342-5. PubMed ID: 16839473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Turn on, tune in, but don't drop out: The impact of neo-liberalism on magic mushroom users' (in)ability to imagine collectivist social worlds.
    Riley S; Thompson J; Griffin C
    Int J Drug Policy; 2010 Nov; 21(6):445-51. PubMed ID: 20810266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The forensic chemical study of psilocybine-containing fungi].
    Babakhanian RV; Bushuev ES; Zenkevich IG; Kazankov SP; Kostyrko TA; Kuz'minykh KS
    Sud Med Ekspert; 1998; 41(6):24-6. PubMed ID: 9989170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psilocybin and psilocin levels in twenty species from seven genera of wild mushrooms in the Pacific Northwest, U.S.A.
    Beug MW; Bigwood J
    J Ethnopharmacol; 1982 May; 5(3):271-85. PubMed ID: 7201053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systematic Error for Extraction of Controlled Substances from Plant/Fungal Materials.
    Nagy J; Veress T
    J Chromatogr Sci; 2020 Oct; 58(10):985-991. PubMed ID: 32945334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience.
    Madsen MK; Stenbæk DS; Arvidsson A; Armand S; Marstrand-Joergensen MR; Johansen SS; Linnet K; Ozenne B; Knudsen GM; Fisher PM
    Eur Neuropsychopharmacol; 2021 Sep; 50():121-132. PubMed ID: 34246868
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of solution conformational preferences for the hallucinogens bufotenin and psilocin using 360-MHz proton NMR spectroscopy.
    Migliaccio GP; Shieh TL; Byrn SR; Hathaway BA; Nichols DE
    J Med Chem; 1981 Feb; 24(2):206-9. PubMed ID: 6259355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure-based discovery of nonhallucinogenic psychedelic analogs.
    Cao D; Yu J; Wang H; Luo Z; Liu X; He L; Qi J; Fan L; Tang L; Chen Z; Li J; Cheng J; Wang S
    Science; 2022 Jan; 375(6579):403-411. PubMed ID: 35084960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.